Found: 4
Select item for more details and to access through your institution.
Results from a first-in-human study of dersimelagon, an investigational oral selective MC1R agonist.
- Published in:
- European Journal of Clinical Pharmacology, 2023, v. 79, n. 6, p. 801, doi. 10.1007/s00228-023-03476-6
- By:
- Publication type:
- Article
Effect of Hepatic and Renal Impairment on the Pharmacokinetics of Dersimelagon (MT‐7117), an Oral Melanocortin‐1 Receptor Agonist.
- Published in:
- Clinical Pharmacology in Drug Development, 2024, v. 13, n. 7, p. 729, doi. 10.1002/cpdd.1413
- By:
- Publication type:
- Article
The Oral Bioavailability and Effect of Various Gastric Conditions on the Pharmacokinetics of Dersimelagon in Healthy Adult Volunteers.
- Published in:
- Clinical Pharmacology in Drug Development, 2023, v. 12, n. 5, p. 493, doi. 10.1002/cpdd.1235
- By:
- Publication type:
- Article
Absorption, metabolism, and excretion of [<sup>14</sup>C]dersimelagon, an investigational oral selective melanocortin 1 receptor agonist, in preclinical species and healthy volunteers.
- Published in:
- Pharmacology Research & Perspectives, 2023, v. 11, n. 3, p. 1, doi. 10.1002/prp2.1084
- By:
- Publication type:
- Article